# Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/survival-and-safety-of-exemestane-versus-tamoxifen-after-2-3-years-tamoxifen/

## Facts

| Field | Value |
| --- | --- |
| Author Names | R. Charles Coombes,Lucy Kilburn,CF Snowdon,Robert Paridaens,RE Coleman,SE Jones,Jacek Jassem,CJH van de Velde,T. Delozier,Isabel Álvarez,Lucia Del Mastro,Olaf Ortmann,K. Diedrich,AS Coates,Emilio Bajetta,Holmberg Sb,David Dodwell,E. Mickiewicz,J. Andersen,Per Eystein Lønning,Giorgio Cocconi,John Forbes,M. Castiglione,N Stuart,A. Stewart,Lesley Fallowfield,Gianfilippo Bertelli,Emma Hall,Richard Bogle,M. Carpentieri,E Colajori,Milayna Subar,Elizabeth Ireland,Judith M. Bliss |
| Citations | 911 |
| DOI | 10.1016/s0140-6736(07)60200-1 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2167238270 |
| PMID | 17307102 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Lesley Fallowfield](https://scholariq.org/researchers/lesley-fallowfield/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.